32 Participants NeededMy employer runs this trial

TP-06 for Corneal Ulcer

(Capellion Trial)

Recruiting at 13 trial locations
SD
SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Tarsus Pharmaceuticals, Inc.
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.

Are You a Good Fit for This Trial?

This trial is for adults with persistent corneal epithelial defects (a type of non-healing sore on the surface of the eye).

Inclusion Criteria

Stable lesion size between Screening and Baseline as assessed by the Investigator
Able and willing to provide written informed consent
I have a non-infected corneal defect in one eye that hasn't healed after 10 days of treatment.

Exclusion Criteria

I have not used any restricted eye medications or procedures.
I currently have an eye infection.
Any condition that, in the Investigator's judgment, would interfere with study participation or interpretation of results
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • TP-06

Trial Overview

The study compares TP-06 eye drops (2.0%) to a placebo (vehicle) in up to 32 adults. Participants use the treatment for 8 weeks, then are monitored for another 2 weeks to check healing and safety.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: TP-06 Ophthalmic SolutionActive Control1 Intervention
Group II: Vehicle of TP-06 Ophthalmic SolutionPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tarsus Pharmaceuticals, Inc.

Lead Sponsor

Trials
10
Recruited
1,300+